Stephen A. Smith found an ally in Howard Stern after Smith’s comments about Serena Williams earned major backlash. Stern, 71, defended ESPN’s Smith, 57, who criticized Williams, 43, for her ...

Telehealth stock Hims & Hers ( HIMS) spiked more than 24% in trading Thursday, days after its Super Bowl ad promoting cheaper GLP-1 weight-loss drugs sparked controversy.

Evrysdi is a non-invasive, disease-modifying option that can be swallowed whole or dispersed in water for patients with ...

Sales of an Alzheimer’s disease treatment were better than expected, but that and a quarterly beat wasn’t enough to offset ...

The stock looks like a decent value, but it could be a bargain if management can execute. Its dividend checks all the boxes ...

Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.

Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative ...

M&A strategy and innovation set it apart. Find out why DNTCF stock is a "Buy" with a fair value estimate of C$11.3 per share.